证券日报网讯 1月6日，爱尔眼科在互动平台回答投资者提问时表示，公司专注眼科医疗，高度关注边 缘交叉学科的动态进展，在创新上鼓励"脑洞大开"，在工作中必须"脚踏实地"。 （文章来源：证券日报） ...

Group 1 - The company, Aier Eye Hospital (300015), focuses on its core business, providing multi-level ophthalmic diagnosis and treatment services for all age groups [1] - The company continuously monitors cutting-edge developments in marginal crossover fields [1]

Group 1 - The company, Chaoyujian Ophthalmology (02219), announced a share buyback plan on January 6, 2026, involving an expenditure of HKD 162,600 to repurchase 60,000 shares [1] - The buyback price range is set between HKD 2.68 and HKD 2.74 per share [1]

Core Viewpoint - The case of Dr. Li Jianhua against Chen, a social media influencer, highlights the judicial protection of citizens' reputation rights and aligns with the national effort to strengthen online governance and punish online crimes [1][9]. Group 1: Background of the Case - Chen, who had no prior connection to Dr. Li, began a campaign of online harassment against him following a medical dispute involving another party, resulting in over two years of defamation through social media [2][10]. - The defamatory statements included accusations of "academic fraud" and "practicing medicine without a license," leading to severe personal and professional consequences for Dr. Li, including mental health issues and disruption of the hospital's operations [2][10]. Group 2: Legal Proceedings - After unsuccessful attempts to resolve the issue amicably, Dr. Li filed a civil lawsuit in November 2021, which resulted in a court ruling against Chen for defamation, requiring him to delete the defamatory content and issue an apology [3][11]. - Despite the civil judgment, Chen continued to spread false information, further damaging Dr. Li's reputation and undermining public trust in the judicial system [3][11]. Group 3: Criminal Charges and Sentencing - Dr. Li subsequently pursued criminal charges against Chen, leading to a conviction for defamation, with the court determining that Chen's actions met the legal criteria for severe circumstances, including high engagement metrics on his defamatory posts [5][14]. - The court sentenced Chen to 18 months in prison, emphasizing the importance of upholding legal standards in online discourse and the consequences of violating others' rights [6][14]. Group 4: Implications for Online Governance - This case serves as a significant precedent in the fight against online defamation and reinforces the message that the internet is not a lawless space, urging citizens to respect legal boundaries while exercising their freedom of expression [7][15]. - The ongoing efforts by the government to enhance online governance, including the implementation of new laws and regulations, aim to create a safer digital environment and reduce instances of online violence and defamation [6][15].

Core Viewpoint - The article provides a detailed explanation of the components of an eye prescription, helping individuals understand the significance of various symbols and numbers on the prescription sheet. Group 1: Eye Identification - The prescription distinguishes between the right eye (R) and left eye (L), with R representing the right eye and L representing the left eye, which is crucial for accurate vision correction [2][3][4]. - Mixing up the data for the right and left eyes can lead to severe eye strain and worsen vision problems [5]. Group 2: Sphere Degree (S) - The sphere degree (S) indicates the degree of myopia or hyperopia, with a "-" sign representing myopia and a "+" sign representing hyperopia [6][7]. - The unit for sphere degree is diopters (DS), and a normal range for adults is ±0.50DS [8][9]. Group 3: Cylinder Degree (C) and Axis (A) - Cylinder degree (C) indicates the degree of astigmatism, while the axis (A) specifies the direction of astigmatism, measured in degrees from 0 to 180° [10][11]. - The unit for cylinder degree is diopters (DC), and a cylinder degree greater than 0.50DC typically requires corrective lenses [12][14]. Group 4: Spherical Equivalent (SE) - The spherical equivalent (SE) is a key indicator of overall refractive status, calculated using the formula: sphere degree + 1/2 cylinder degree [15][16]. Group 5: Pupillary Distance (PD) - Pupillary distance (PD) is essential for comfortable lens fitting, with a normal range for adults being 55-70mm [17][18]. - Accurate measurement of PD is critical to avoid discomfort and visual distortion [19]. Group 6: Important Reminders - The prescription data should be analyzed in conjunction with age, medical history, and visual habits for accurate assessment [20]. - Children require specific considerations for eye exams, including the need for dilation and frequent re-evaluations due to rapid vision changes [21][23]. - It is advised to retain the prescription for future reference, as it may fade over time, and to avoid purchasing glasses online without proper fitting [24][25].

2026年1月4日，南京维视眼科医院成功完成全国首批EVO+ICL(V5)有晶体眼人工晶体植入手术。 此次手术的顺利落地，标志着南京维视眼科在屈光矫正领域与国际先进技术实现同步接轨，为近视患者 带来"昼夜高清"的视觉新体验，助力屈光手术迈入个性化精准矫正新阶段。 01——四大核心优势，助力提升视觉新体验 据STAAR Surgical公司提供的产品特性显示，EVO+ICL (V5)具有以下四大技术特点： 更大光学区，日夜高清视界新突破： 区设计，旨在改善夜间等低光照环境下的对比敏感度与视觉质量，助力提升全天候视觉体验。 瑞士精工制造，卓越品质前沿体验： 依托瑞士高精度加工工艺，每一处细节都追求极致精准，持续创新迭代，力求带来国际前沿的卓越视觉 享受。 独有Collamer材料，持久稳定守护高清视界： 其采用的专利Collamer材料，具有生物相容性高、柔韧及可阻挡紫外线的特性，为长期稳定的视觉效果 提供了材料学基础。 30余年临床验证，300万+全球信赖： ICL(植入式Collamer晶体)技术已拥有超过30年的全球临床应用历史。截至当前，已在全球多地开展应 用。作为一种"加法"型屈光手术，其不切削角膜、必 ...

Core Viewpoint - He Eye Hospital is advancing in the field of gene therapy, focusing on hereditary eye diseases and offering a range of services including genetic testing and personalized risk screening [2] Group 1: Gene Therapy Initiatives - He Eye Hospital, led by renowned expert Professor Pang Jijing, has established a specialized clinic for hereditary eye diseases [2] - The clinic provides services such as genetic testing, diagnosis, treatment, personalized risk screening, and health management for hereditary eye disease patients and their families [2] Group 2: Business Developments - The company is progressing with the acquisition of overseas Medial Corporation, which is involved in stem cell exosome research [2] - The business scope of the acquisition includes the development of anti-aging products [2] - Current developments have not significantly impacted the company's main business operations or performance [2]

Group 1 - The core viewpoint of the news is that Huaxia Eye Hospital has shown a slight decline in stock price and has experienced significant financing activities, indicating a mixed sentiment among investors [1] - As of December 31, Huaxia Eye Hospital's stock price fell by 0.06%, with a trading volume of 55.95 million yuan. The net financing buy was -4.74 million yuan, indicating more financing repayment than buying [1] - The total financing and securities balance for Huaxia Eye Hospital reached 192 million yuan, with the financing balance accounting for 1.26% of the circulating market value, which is above the 90th percentile of the past year [1] Group 2 - As of September 30, the number of shareholders for Huaxia Eye Hospital increased to 21,200, a rise of 0.58%, while the average circulating shares per person decreased by 0.57% to 15,489 shares [2] - For the period from January to September 2025, Huaxia Eye Hospital reported a revenue of 3.272 billion yuan, reflecting a year-on-year growth of 2.83%, and a net profit attributable to shareholders of 434 million yuan, up by 3.04% [2] - Since its A-share listing, Huaxia Eye Hospital has distributed a total of 507 million yuan in dividends [3]

Group 1 - BYD aims to maintain significant R&D and financial investment to consolidate electrification and promote intelligence in the new "15th Five-Year Plan" period [3] - The company plans to integrate global resources for collaborative innovation and accelerate its global industrial layout to build a world-class Chinese brand [3] - BYD's annual sales have achieved a tenfold growth during the "14th Five-Year Plan" period, establishing it as the largest electric vehicle manufacturer globally [3] Group 2 - Oriental Fortune emphasizes the importance of empowering the real economy and serving people's needs in the financial sector during the "15th Five-Year Plan" [5] - The company aims to leverage technology to connect wealth management and financing needs effectively [5] Group 3 - Moore Threads focuses on accelerating the application of domestic GPUs across various industries to support digital transformation [7] - The company has established a complete technology stack based on a unified architecture, achieving a systematic closed loop from hardware to application [7] Group 4 - Muyuan Foods is committed to producing safe and healthy pork products, aiming for high-quality development in the pig farming industry [9] - The company plans to leverage technology to address industry challenges and contribute to the high-quality development of China's pig farming sector [9] Group 5 - Zhongwei Company aims to achieve 50% to 60% market coverage in high-end semiconductor equipment through organic growth and external expansion [12] - The company emphasizes the importance of technological innovation and industry chain collaboration to enhance global competitiveness [12] Group 6 - Huayou Cobalt plans to align its strategy with national planning during the "15th Five-Year Plan" period, focusing on creating customer value and leading industry development [16] - The company aims to become a leading technology enterprise in energy materials globally [16] Group 7 - Aier Eye Hospital integrates clinical services, research innovation, and public health education into a comprehensive eye health ecosystem [18] - The company is committed to advancing AI diagnostics and expanding its eye health service network [18] Group 8 - Tianci Materials focuses on sustainable development principles, enhancing innovation capabilities in lithium-ion battery materials and specialty chemicals [20] - The company aims to embrace a new growth cycle in the lithium and energy storage industry over the next five years [20] Group 9 - JinkoSolar emphasizes technological innovation as the core driver of its development, aiming to enhance the efficiency of photovoltaic applications [22] - The company is focused on integrating advanced technologies with traditional manufacturing to foster new productive forces [22] Group 10 - Jishi Media aims to integrate cultural and technological advancements, focusing on digital transformation and innovation in the media sector [24] - The company plans to enhance its competitiveness by focusing on AI, data elements, and low-altitude economy [24] Group 11 - China National Machinery Industry Corporation aims to transform into a technology-driven engineering company while embedding its development into the national modernization blueprint [26] - The company plans to enhance its efficiency and investment value through capital market engagement and focus on green engineering and digital infrastructure [26]

Core Viewpoint - The article emphasizes the strategic plans and aspirations of various companies as they embark on the "15th Five-Year Plan" period, highlighting their commitment to innovation, technology, and global competitiveness. Group 1: BYD - BYD aims to maintain significant R&D and financial investment to solidify its position in electrification and promote smart technology, leveraging global resources for innovation [4] - The company has achieved a tenfold increase in annual sales during the "14th Five-Year Plan" and seeks to capitalize on the global expansion of Chinese brands [4] Group 2: Oriental Fortune - Oriental Fortune expresses confidence in the resilience of the Chinese economy and emphasizes the importance of financial technology in connecting wealth management with real economy financing [6] - The company aims to serve diverse stakeholders and enhance its role in the financial transformation landscape [6] Group 3: Moore Threads - Moore Threads focuses on accelerating the application of domestic GPUs across various industries, contributing to the digital transformation [8] - The company has established a comprehensive technology stack and aims to maintain high R&D investment to strengthen its competitive edge [8] Group 4: Muyuan Foods - Muyuan Foods is committed to producing safe and healthy pork products, responding to consumer demand while advancing the pig farming industry towards high-quality development [10] - The company plans to leverage technology to address industry challenges and enhance overall quality [10] Group 5: Zhongwei Company - Zhongwei Company aims to achieve 50% to 60% market coverage in high-end semiconductor equipment through organic growth and expansion over the next five to ten years [12] - The company emphasizes collaboration within the industry to enhance global competitiveness [12] Group 6: AVIC Shenyang Aircraft - AVIC Shenyang Aircraft is focused on achieving significant milestones in the "15th Five-Year Plan" by enhancing core functions and competitiveness [14] - The company aims to contribute to the construction of a strong aviation nation through strategic initiatives [14] Group 7: Huayou Cobalt - Huayou Cobalt plans to align its strategy with national planning during the "15th Five-Year Plan," focusing on creating customer value and leading industry development [16] - The company aims to become a leading technology enterprise in energy materials [16] Group 8: Aier Eye Hospital - Aier Eye Hospital integrates its development with national strategies, focusing on innovation in eye health services and technology [18] - The company aims to enhance its service network and collaborate with partners to improve public health outcomes [18] Group 9: Tinci Materials - Tinci Materials is committed to sustainable development through innovation in lithium-ion battery materials and specialty chemicals [21] - The company anticipates a new growth cycle in the lithium and energy storage industries over the next five years [21] Group 10: JinkoSolar - JinkoSolar emphasizes technology innovation as a core driver for its development, focusing on high-efficiency solar cell technologies [23] - The company aims to integrate advanced technologies with traditional manufacturing to foster new productive capabilities [23] Group 11: Jishi Media - Jishi Media aims to integrate cultural and technological advancements, focusing on becoming a leading cultural technology enterprise [25] - The company plans to leverage AI and digital transformation to enhance its service offerings [25] Group 12: China National Machinery Industry Corporation - China National Machinery Industry Corporation is focused on deepening its role in China's modernization efforts while enhancing its international competitiveness [27] - The company aims to foster new productive capabilities in emerging sectors such as green engineering and digital infrastructure [27]